Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Posner, K. Articles by Davies, M. Search for Related Content PubMed Citation Articles by Posner, K. Articles by Davies, M. Suicide Antidepressants Related Articles

Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants

OBJECTIVE: To evaluate the link between antidepressants and suicidal behavior and ideation (suicidality) in youth, adverse events from pediatric clinical trials were classified in order to identify suicidal events. The authors describe the Columbia Classification Algorithm for Suicide Assessment (C-CASA), a standardized suicidal rating system that provided data for the pediatric suicidal risk analysis of antidepressants conducted by the Food and Drug Administration (FDA). METHOD: Adverse events (N=427) from 25 pediatric antidepressant clinical trials were systematically identified by pharmaceutical companies. Randomly assigned adverse events were evaluated by three of nine independent expert suicidologists using the Columbia classification algorithm. Reliability of the C-CASA ratings and agreement with pharmaceutical company classification were estimated. RESULTS: Twenty-six new, possibly suicidal events (behavior and ideation) that were not originally identified by pharmaceutical companies were identified in the C-CASA, and 12 events originally labeled as suicidal by pharmaceutical companies were eliminated, which resulted in a total of 38 discrepant ratings. For the specific label of "suicide attempt," a relatively low level of agreement was observed between the C-CASA and pharmaceutical company ratings, with the C-CASA reporting a 50% reduction in ratings. Thus, although the C-CASA resulted in the identification of more suicidal events overall, fewer events were classified as suicide attempts. Additionally, the C-CASA ratings were highly reliable (intraclass correlation coefficient [ICC]=0.89). CONCLUSIONS: Utilizing a methodical, anchored approach to categorizing suicidality provides an accurate and comprehensive identification of suicidal events. The FDA’s audit of the C-CASA demonstrated excellent transportability of this approach. The Columbia algorithm was used to classify suicidal adverse events in the recent FDA adult antidepressant safety analyses and has also been mandated to be applied to all anticonvulsant trials and other centrally acting agents and nonpsychotropic drugs.

Related Articles:

Antidepressants and Suicidal Behavior: Cause or Cure?

David Brent
Am J Psychiatry 2007 164: 989-991. [Full Text] [PDF]

This article has been cited by other articles:

				M. Stone, T. Laughren, M L. Jones, M. Levenson, P C. Holland, A. Hughes, T. A Hammad, R. Temple, and G. Rochester Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration BMJ, August 11, 2009; 339(aug11_2): b2880 - b2880. [Abstract] [Full Text] [PDF]

				M. M. Weissman Teenaged, Depressed, and Treatment Resistant: What Predicts Self-Harm? Am J Psychiatry, April 1, 2009; 166(4): 385 - 385. [Full Text] [PDF]

				D. A. Brent, G. J. Emslie, G. N. Clarke, J. Asarnow, A. Spirito, L. Ritz, B. Vitiello, S. Iyengar, B. Birmaher, N. D. Ryan, et al. Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study Am J Psychiatry, April 1, 2009; 166(4): 418 - 426. [Abstract] [Full Text] [PDF]

				B. D. Kennard, S. G. Silva, T. L. Mayes, P. Rohde, J. L. Hughes, B. Vitiello, C. J. Kratochvil, J. F. Curry, G. J. Emslie, M. A. Reinecke, et al. Assessment of Safety and Long-Term Outcomes of Initial Treatment With Placebo in TADS Am J Psychiatry, March 1, 2009; 166(3): 337 - 344. [Abstract] [Full Text] [PDF]

				C. Barbui MD, E. Esposito MD, and A. Cipriani MD Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies Can. Med. Assoc. J., February 3, 2009; 180(3): 291 - 297. [Abstract] [Full Text] [PDF]

				M. A. Oquendo, E. Baca-Garcia, J. J. Mann, and J. Giner Issues for DSM-V: Suicidal Behavior as a Separate Diagnosis on a Separate Axis Am J Psychiatry, November 1, 2008; 165(11): 1383 - 1384. [Full Text] [PDF]

				M. K. Nock, G. Borges, E. J. Bromet, C. B. Cha, R. C. Kessler, and S. Lee Suicide and Suicidal Behavior Epidemiol. Rev., November 1, 2008; 30(1): 133 - 154. [Abstract] [Full Text] [PDF]

				B. Vitiello and J. L. Pearson A Depressed Adolescent at High Risk of Suicidal Behavior Am J Psychiatry, March 1, 2008; 165(3): 323 - 328. [Full Text] [PDF]

				L. Van Gaal, X. Pi-Sunyer, J.-P. Despres, C. McCarthy, and A. Scheen Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program Diabetes Care, February 1, 2008; 31(Supplement_2): S229 - S240. [Abstract] [Full Text] [PDF]

				Bibliography for Major Depressive Disorder and Suicide Focus, January 1, 2008; 6(1): 58 - 62. [Full Text] [PDF]

				A. James Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY Adv. Psychiatr. Treat., January 1, 2008; 14(1): 10 - 16. [Abstract] [Full Text] [PDF]

				R. D. Gibbons, C. H. Brown, K. Hur, S. M. Marcus, D. K. Bhaumik, J. A. Erkens, R. M.C. Herings, and J. J. Mann Early Evidence on the Effects of Regulators' Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents Am J Psychiatry, September 1, 2007; 164(9): 1356 - 1363. [Abstract] [Full Text] [PDF]

				Emerging Perspectives: Look Again -- SSRIs and Fewer Suicide Attempts Journal Watch Psychiatry, July 13, 2007; 2007(713): 1 - 1. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us